RHÖN-KLINIKUM AG 

18.06.2012 12:15

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.



Notification according to section 26 para. 1 WpHG 

On 14 June 2012, SEB AG, Frankfurt, Germany, and Skandinaviska Enskilda
Banken AB (publ), Stockholm, Sweden, notified us pursuant to section 25
WpHG of the following:

1) SEB AG, Frankfurt, Germany, notified us pursuant to section 25 para. 1
WpHG of the following:

On 13 June 2012, SEB AG exceeded the threshold of 10% of the voting rights
of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale,
Germany. On that date, SEB AG held 10.13% of the voting rights in
RHÖN-KLINIKUM AG (equals 14,004,333 voting rights). From these voting
rights a proportion of 9.89% (equals 13,668,833 voting rights) is based on
voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.24%
(equals 335,000 voting rights) is based on (financial/other) instruments
pursuant to section 25 WpHG. From the voting rights based on instruments
pursuant to section 25 WpHG a proportion of 0.00% (equals 0 voting rights)
is held indirectly. Exercise period of the instruments pursuant to section
25 WpHG is any time until cancellation/claim for the return of shares,
maturity upon cancellation/claim for the return of shares.

2) Skandinaviska Enskilda Banken AB (publ), Stockholm, Sweden, notified us
pursuant to section 25 WpHG of the following:

On 13 June 2012, Skandinaviska Enskilda Banken AB (publ) exceeded the
threshold of 15% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1,
97616 Bad Neustadt a. d. Saale, Germany. On that date, SEB AG held 15.03%
of the voting rights in RHÖN-KLINIKUM AG (equals 20,773,237 voting rights).
From these voting rights a proportion of 9.89% (equals 13,668,833 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 5.14% (equals 7,104,404 voting rights) is based on
(financial/other) instruments pursuant to section 25 WpHG. From the voting
rights based on instruments pursuant to section 25 WpHG a proportion of
0.24% (equals 335,500 voting rights) is held indirectly (chain of
controlled undertakings: SEB AG, Ulmenstraße 30, 60325 Frankfurt, Germany).
Exercise period of the instruments pursuant to section 25 WpHG is any time
until cancellation/claim for the return of shares, maturity upon
cancellation/claim for the return of shares.

Bad Neustadt a.d. Saale, 18 June 2012

The Board of Management

___________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax:       +49 9771 99 - 1736



18.06.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service